Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial

Autor: Alkhouri, Naim, Herring, Robert, Kabler, Heidi, Kayali, Zeid, Hassanein, Tarek, Kohli, Anita, Huss, Ryan S., Zhu, Yanni, Billin, Andrew N., Damgaard, Lars Holm, Buchholtz, Kristine, Kjær, Mette Skalshøi, Balendran, Clare, Myers, Robert P., Loomba, Rohit, Noureddin, Mazen
Zdroj: In Journal of Hepatology September 2022 77(3):607-618
Databáze: ScienceDirect
Externí odkaz: